The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

With $190M in in­vestor cash to play with, Chi­na's Chime Bi­o­log­ics looks to build 15x man­u­fac­tur­ing ca­pac­i­ty by 2024

5 years ago
Deals

Chi­nese CD­MO Ray­bow quadru­ples work­force at NC site, hop­ing to help build next bio­phar­ma man­u­fac­tur­ing hub

5 years ago
R&D

From an­tipasti to an­tivi­rals: Ginkgo's qui­et quest to re­make how mR­NA vac­cines are made

5 years ago

No­var­tis walks away from 3rd Zol­gens­ma plant just a year af­ter leas­ing it as it piv­ots re­sources to next-gen pipeline

5 years ago
Pharma

Covid-19 man­u­fac­tur­ing roundup: As­traZeneca de­nies stock­pil­ing claims; Vir­chow Biotech to make Sput­nik V vac­cine in In­dia — Reuters

5 years ago

T cell ther­a­py play­er Lyell pre­pares to open $65M man­u­fac­tur­ing fa­cil­i­ty in the Seat­tle area

5 years ago

Ex­clu­sive: An in­dus­try con­sor­tium wants to stan­dard­ize cell track­ing for re­gen­er­a­tive meds. Could that avert a dis­as­ter?

5 years ago
Cell/Gene Tx

In­no­force gets $96M to build up Chi­na cam­pus, in­clud­ing a new Ther­mo Fish­er-part­nered mon­o­clon­al an­ti­body man­u­fac­tur­ing fa­cil­i­ty

5 years ago
Cell/Gene Tx

Drum­roll, please: Fu­ji­film Diosynth picks North Car­oli­na as new home for $2B cell-cul­ture su­per­plant

5 years ago

In­side No­var­tis' months-long ef­forts to scale their ri­val­s' Covid-19 vac­cines

5 years ago
Coronavirus

Re­call re­port: Sagent Phar­ma pulls low blood pres­sure med for loose seal­ing on ster­ile vials

5 years ago
FDA+

Catal­ent amps up plans to man­u­fac­ture J&J's Covid-19 vac­cine, adding vial fill­ing line in Italy

5 years ago

Covid-19 man­u­fac­tur­ing roundup: Catal­ent, As­traZeneca de­fend vac­cine batch qual­i­ty in safe­ty row — FT; US buys more Covid-19 an­ti­body sup­plies

5 years ago
Coronavirus

Mer­ck KGaA adds 350 work­ers at French site to build ca­pac­i­ty for 's­in­gle-use' tech for Covid-19 vac­cines, ther­a­pies

5 years ago
Outsourcing

Pfiz­er lays down its hand on Chi­nese biosims, of­fload­ing its 3-year-old plant to WuXi Bi­o­log­ics as com­pe­ti­tion grows

5 years ago

El­e­vate­Bio adds an­oth­er $525M to its war chest as it looks to build on next-gen man­u­fac­tur­ing 'base­cam­p'

5 years ago
Financing
Cell/Gene Tx

Ani Phar­ma picks up gener­ic play­er for a cool $210M, tur­bocharg­ing its man­u­fac­tur­ing and R&D wings

5 years ago
Outsourcing

Covid-19 man­u­fac­tur­ing roundup: Biden dou­bles down on vac­ci­na­tion plan with 100M-dose or­der; BioN­Tech, Pfiz­er ready to in­crease man­u­fac­tur­ing; J&J ex­pe­ri­ences de­liv­ery woes

5 years ago
Coronavirus

Re­call re­port: BRP Phar­ma pulls 47 bot­tles of gener­ic di­uret­ic spirono­lac­tone af­ter mix­ing dif­fer­ent strength pills

5 years ago
Pharma
FDA+

Syn­thet­ic DNA play­er Touch­light scores $60M round to more than triple man­u­fac­tur­ing ca­pac­i­ty as mR­NA gets hot

5 years ago
Financing

Ther­mo Fish­er will drop a whop­ping $600M in­to its man­u­fac­tur­ing sup­ply chain as Covid-19 work ramps up

5 years ago
Outsourcing

Eli Lil­ly pro­motes Edgar­do Her­nan­dez to head its man­u­fac­tur­ing op­er­a­tions as 19-year vet O'Neill hits the ex­it

5 years ago
People

FDA in­spec­tion back­log tops 1,000 — and could last for years — as House hear­ing rais­es se­ri­ous con­cerns

5 years ago
FDA+

Mod­er­na finds a con­tract man­u­fac­tur­ing part­ner to scale up vac­cine sup­ply

5 years ago
R&D
First page Previous page 74757677787980 Next page Last page
A service from the Financial Times